The largest database of trusted experimental protocols

Milliplex human cardiovascular disease panels

Manufactured by Merck Group
Sourced in United States

The Milliplex Human Cardiovascular Disease panels are a set of multiplex assays designed to measure a variety of cardiovascular disease-related analytes in human biological samples. The panels utilize the Luminex xMAP technology to enable simultaneous quantification of multiple analytes from a single sample. The core function of these panels is to provide a comprehensive and efficient way to analyze cardiovascular biomarkers in research and clinical settings.

Automatically generated - may contain errors

7 protocols using milliplex human cardiovascular disease panels

1

Cardiovascular Disease Biomarkers Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testing was conducted using Milliplex Human Cardiovascular Disease panels (EMD Millipore, USA) as outlined in the manufacturer’s protocols. Soluble biomarkers assessed included MMP-9, tPAI-1, hsCRP, IL-6, IL-8, IL-10, TNF-α, soluble E-selectin (sE-selectin), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular cell adhesion molecule-1 (sICAM-1), monocyte chemoattractant protein-1 (MCP-1), and interferon-gamma (IFN-γ).
+ Open protocol
+ Expand
2

Quantification of Circulating cfDNA and NET Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Circulating cfDNA in the plasma was quantified using the Quant-iT™ PicoGreen™ dsDNA Assay-Kit (ThermoScientific, P11496) according to the manufacturer's instructions. The fluorescence was read in a VICTOR3 plate reader (Perkin Elmer) by fluorescence 485 nm/535 nm, 1.0 s protocol. The concentration of the circulating cfDNA was calculated based on the standard provided by the kit. CitH3 was quantified in plasma using the enzyme-linked immunosorbent assay according to the manufacturer’s instructions (Cayman, 501620). We used previously generated plasma cytokine data to assess associations of circulating NET markers and LDG parameters with soluble biomarkers in PLWH. List of cytokines in Table 2 was measured via a MILLIPLEX® Human Cardiovascular Disease panels (EMD Millipore) according to the manufacturers protocol.
+ Open protocol
+ Expand
3

Multiplex Biomarker Profiling of Cardiovascular Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testing was conducted using Milliplex Human Cardiovascular Disease panels (EMD Millipore, USA) as outlined in the manufacturer’s protocols. Soluble biomarkers assessed included MMP-9, MPO, tPAI-1, CRP, SAA, SAP, IL-1β, IL-6, IL-8, IL-10, TNF-α, soluble E-selectin (sE-selectin), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular cell adhesion molecule-1 (sICAM-1), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), interferon-gamma (IFN-γ), and N-terminal pro-brain natriuretic peptide (NT-proBNP).
+ Open protocol
+ Expand
4

Multiplex Biomarker Analysis of HIV Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aliquots of plasma from 74 HIV-infected individuals on cART were used for multiplex biomarker analysis using Milliplex human cardiovascular disease panels (EMD Millipore, USA). Soluble biomarkers assessed included sE-selectin, sVCAM-1, sICAM-1, matrix metalloprotease 9 (MMP-9), myeloperoxidase (MPO), plasminogen activator inhibitor-1 (tPAI-1), C-reactive protein (CRP), serum amyloid A (SAA), serum amyloid P (SAP), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), IL-1β, IL-6, IL-8, IL-10, tumor necrosis factor alpha (TNF-α), and gamma interferon (IFN-γ). Standards and samples were measured in duplicate. Samples were acquired on a Luminex 200 instrument (R&D Systems, Inc.). Bio-Plex Manager 6.1 software (Bio-Rad Laboratories, Inc.) was used for data processing.
+ Open protocol
+ Expand
5

Cytokine Profiling in HIV+ Individuals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was separated within 30 minutes of the blood draw and plasma aliquots were cryopreserved until used for cytokine/chemokine assessments in a subset of the HIV+ individuals. Testing was conducted using Milliplex Human Cardiovascular Disease panels (EMD Millipore, USA) as outlined in the manufacturer’s protocols. The soluble biomarkers assessed were IL-6, IL-8, IL-10, and TNF-α.
+ Open protocol
+ Expand
6

Cardiovascular Biomarker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasma soluble biomarkers, matrix metallopeptidase-9, myeloperoxidase, tissue plasminogen activator inhibitor-1, C-reactive protein, serum amyloid A, serum amyloid P, interleukin (IL)-1β, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-α, soluble E-selectin, soluble vascular cell adhesion molecule-1, soluble intercellular cell adhesion molecule-1 (sICAM-1), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor, interferon-gamma (IFN-γ), and N-terminal pro-brain natriuretic peptide were measured by Milliplex Human Cardiovascular Disease panels (EMD Millipore, Temecula, CA) as outlined in the manufacturer's protocols as previously described (40 (link)).
+ Open protocol
+ Expand
7

Measurement of Cardiovascular Biomarkers and Dysfunction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood samples were collected (nothing by mouth for 12 hours except water), stored in EDTA tubes, frozen at −1400C and forwarded to LipoScience Inc. (Raleigh, NC). Chemiluminescent immunoassay (DiaSorin) was used to measure serum 25(OH)D levels.
Milliplex Human Cardiovascular Disease panels (EMD Millipore) were used to measure the following plasma soluble biomarkers: C-reactive protein (CRP), interferon-gamma (IFN-γ), interleukin-1beta (IL-1β), IL-6, IL-8, IL-10, matrix metallopeptidase-9 (MMP-9), monocyte chemoattractant protein-1 (MCP-1), myeloperoxidase (MPO), plasminogen activator inhibitor type 1 (PAI-1), serum amyloid A (SAA), serum amyloid P component (SAP), soluble E-selectin (sE-selectin), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), tumor necrosis factor-alpha (TNF-α), and vascular endothelial growth factor (VEGF).
Three different markers of arterial dysfunction were available in the database: carotid intima media thickness (cIMT), flow-mediated dilatation (FMD), and coronary artery calcium (CAC). Methods utilized to obtain cIMT, FMD, and CAC have been previously published.[5] (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!